Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Its portfolio includes medicines and vaccines across oncology, internal medicine, hospital products, and rare disease.
Pfizer Inc. operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for PFE.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). PFE Stock Intelligence Report. [stoxpulse.com/stocks/pfe]
Disclaimer: The information on this page about Pfizer Inc. (PFE) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Pfizer Inc..
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 4%
Mar 31
Pfizer licenses Chai Discovery AI platform for dru...
6h ago
Investors are taking profits ahead of SpaceX IPO, ...
6h ago
StoxPulse AI results for PFE: Pulse Score 48/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$148.39B
P/E Ratio
18.2
EPS
$-0.29
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+32.9%
Sep 25
+36.0%
Dec 25
+14.3%
Mar 26
+3.5%
Beat estimates 4 of 4 quarters (100%)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Its portfolio includes medicines and vaccines across oncology, internal medicine, hospital products, and rare disease.
Pfizer licenses Chai Discovery AI platform for drug discovery
Investors are taking profits ahead of SpaceX IPO, says Capital Wealth's Kevin Simpson
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
Pfizer signs licence agreement with Chai for AI drug discovery
75% Upside For LLY Stock?
Pfizer Taps Chai Discovery AI To Expand Biologics Pipeline Potential
Why Is Pfizer (PFE) Down 4.5% Since Last Earnings Report?
Does Decnupaz Approval Validate ABBV's ADC Strategy in Oncology?